Nearly one in three people or about 30 per cent treated for SARS-CoV-2 are likely to develop post acute sequelae of Covid-19 (PASC), most commonly known as long Covid.

People with a history of hospitalisation, diabetes, and higher body mass index were most likely to develop the condition, while those who had undergone an organ transplant were less likely to develop it.

Surprisingly, ethnicity, older age, and socioeconomic status were not associated with the syndrome even though those characteristics have been linked with severe illness and greater risk of death from Covid-19.

Researchers from the University of California – Los Angeles analysed 309 people with long Covid. They found fatigue and shortness of breath (31 per cent and 15 per cent, respectively) to be the most persistent symptoms in hospitalised persons, and loss of sense of smell (16 per cent) in outpatients.

The incidence and risk factors of Long Covid, and even how to define the syndrome, have remained unclear throughout the pandemic.

“This study illustrates the need to follow diverse patient populations longitudinally to understand the long Covid disease trajectory and evaluate how individual factors such as pre-existing co-morbidities, sociodemographic factors, vaccination status and virus variant type affect type and persistence of long Covid symptoms,” said Dr Sun Yoo, health sciences assistant clinical professor at UCLA.

In March, University of Cambridge in the UK reported results of twin studies that showed seven in 10 long Covid patients experience concentration and memory problems several months after the initial onset of their disease, with many performing worse than their peers on cognitive tests.

The results revealed a consistent pattern of ongoing memory problems in those who had suffered Covid-19 infection. Problems were more pronounced in people whose overall ongoing symptoms were more severe.

“Studying outcomes in a single health system can minimise variation in quality of medical care. Because persistent symptoms can be subjective in nature, we need better tools to accurately diagnose long Covid and to differentiate it from exacerbations of other emerging or chronic conditions,” Yoo said.

Yoo also presses the need to ensure equitable access to outpatient long Covid care.

–IANS

rvt/svn/

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear Reader,

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.

We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor